(Q35888693)

10 August 2017

1 reference

title

Graft-versus-host disease in mini-transplant (English)

1 reference

10 August 2017

Shin Mineishi

1

1 reference

10 August 2017

Friedrich G Schuening

series ordinal

2

1 reference

10 August 2017

publication date

1 October 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

45

1 reference

10 August 2017

issue

10

1 reference

10 August 2017

page(s)

1969-1980

1 reference

Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Chronic but not acute graft-versus-host disease improves outcome in multiple myeloma patients after non-myeloablative allogeneic transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Allogeneic Stem-Cell Transplantation From Related and Unrelated Donors in Older Patients With Myeloid Leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Follow‐up of patients with progressive multiple myeloma undergoing allografts after reduced‐intensity conditioning

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Allogeneic stem cell transplantation in the myelodysplastic syndromes: interim results of outcome following reduced-intensity conditioning compared with standard preparative regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Allogeneic stem-cell transplantation of renal cell cancer after nonmyeloablative chemotherapy: feasibility, engraftment, and clinical results

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results of a prospective multicentre study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Long-Term follow-up of recipients of CD8-depleted donor lymphocyte infusions for the treatment of chronic myelogenous leukemia relapsing after allogeneic progenitor cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

In vitro T-cell receptor V beta repertoire analysis may identify which T-cell V beta families mediate graft-versus-leukaemia and graft-versus-host responses after human leucocyte antigen-matched sibling stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

Infusion of select leukemia-reactive TCR Vbeta+ T cells provides graft-versus-leukemia responses with minimization of graft-versus-host disease following murine hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F1042819042000219511

10.1080/1042819042000219511

21 January 2018

Identifiers

DOI

1 reference

10 August 2017

1 reference